Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Abeona Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 33 | 37 | +4 |
| Shares | 7.53M | 9.39M | +1.87M (+24.8%) |
| Value | $21.2M | $37.9M | +$16.6M (+78.4%) |
New holders (9)
Institutions that held Abeona Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 498,044 | $2.01M | 0.11% |
| Citigroup Inc | 200,000 | $806.0K | 0.00% |
| Virtu Financial LLC | 32,171 | $130.0K | 0.01% |
| CI Private Wealth, LLC | 13,902 | $56.0K | 0.00% |
| Bank of New York Mellon Corp | 12,934 | $52.1K | 0.00% |
| UBS Group AG | 1,105 | $4.45K | 0.00% |
| Simplex Trading, LLC | 710 | $2.00K | 0.00% |
| Rhumbline Advisers | 58 | $233 | 0.00% |
| FMR LLC | 16 | $64 | 0.00% |
Sold out (5)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ExodusPoint Capital Management, LP | 120,853 | $341.0K |
| Creative Planning | 22,011 | $62.1K |
| Charles Schwab Investment Management Inc | 18,000 | $50.8K |
| Phoenix Holdings Ltd. | 11,874 | $33.3K |
| Tower Research Capital LLC (TRC) | 640 | $2.00K |